Panelist: Matt Kane, CEO

Scientific Talk: Ex vivo and in vivo therapeutic applications of ARCUS gene editing
Speaker: Amy Rhoden-Smith, PhD, Development Program Leader

Talk: Enhancing T cell fitness and expansion
Speaker: Chris Heery, MD, Chief Medical Officer
Date: Sep 15, 2020 at 11:50 AM ET

Panel: Realizing the promise of ATMPs for patients around the world
Speaker: Chris Heery, MD, Chief Medical Officer
Date: Sep 8, 2020 at 9:30 AM ET (14:30 BST)

Talk: Allogenic CAR T in the clinic and prospects for making CAR T more accessible to patients
Speaker: Chris Heery, MD, Chief Medical Officer
Date: Sep 10, 2020 at 8:00 AM ET (13:00 BST)

Panel: Exploring advances in gene editing technology, research and ethical questions
Moderator: Dave Morris, PhD, Vice President, Therapeutic Discovery
Date: Sep 11, 2020 at 5:30 AM ET (10:30 BST)

Talk: In vivo gene editing capabilities of ARCUS meganucleases
Speaker: Dave Morris, PhD, Vice President, Therapeutic Discovery
Date: Sep 11, 2020 at 10:00 AM ET (15:00 BST)

Talk: Engineering gene-edited off-the-shelf CAR T cells to reduce immunogenicity and improve activity
Speaker: Dan MacLeod, PhD, Senior Director, Cell Therapy Research
Date: Sep 2, 2020 at 1:05 PM ET